Loading...
NPI 1598106163 · Phoenix, AZ · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Central Clinical Labs Incorporated is a clinical medical laboratory provider located in Phoenix, Arizona. This profile covers 186 Medicare and 170 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Central Clinical Labs Incorporated |
| Address | 3720 E La Salle St Ste 103 |
| City | Phoenix |
| State | AZ |
| ZIP | 85040 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | July 11, 2013 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $6.1M |
| Medicare | $3.5M |
CENTRAL CLINICAL LABS INCORPORATED’s code mix and top revenue drivers indicate a clinical laboratory with a substantial mobile/home-collection component: travel allowance codes P9604 and P9603 appear prominently on both payers (Medicare P9604 $376.2K revenue and P9603 $219K revenue; Medicaid P9604 $1.1M revenue and P9603 $105.9K revenue), paired with routine laboratory panels and monitoring tests such as 80053, 85025, 84443, 80061 and 82306. This combination of travel allowances plus high volumes of common chemistry, hematology and endocrine assays suggests the operation is structured to collect specimens from home-bound or SNF populations and then perform centralized lab testing.
Revenue concentration is material for both payers: the precomputed top-3 codes account for 32.2% of this provider’s total Medicare revenue and 37.1% of its total Medicaid revenue, indicating that a relatively small set of CPT/HCPCS codes drive a large share of billing. That concentration raises operational dependence on the specific services represented by those top codes (notably travel/collection and a handful of high-volume panels).
The provider’s payer mix is skewed toward Medicaid in scale: reported lifetime revenue is $3.5M from Medicare and $6.1M from Medicaid, making Medicaid the larger revenue source on file. This asymmetric payer footprint means Medicaid reimbursement patterns and state-level contracting will have more influence on the provider’s topline than Medicare.
For Medicare, CENTRAL CLINICAL LABS shows national high-volume standing on several specimen-collection and common phlebotomy codes: 36415 is an extreme outlier with 41.1K claims and $328.7K revenue (10.9% of Medicare revenue) and ranks #77 of 86467 providers nationally (100th percentile), while P9604 ($376.2K, 12.5% of Medicare revenue) ranks #7 of 400 providers nationally (98th percentile) and is described as notably above typical national volume. These rank/percentile placements indicate the provider is a national high-volume participant for basic collection and routine blood-draw services.
At the state Medicaid level the provider is dominant on travel-based collection: Medicaid P9604 registers 138.4K claims and $1.1M revenue (21.8% of Medicaid revenue) and ranks #1 of 12 providers in-state (100th percentile; extreme outlier). In addition, tests commonly used for chronic disease monitoring and population screening — for example 82306 ($441.4K, 8.7% of Medicaid revenue, rank #3 of 99 in-state) and 80053 ($332.8K, 6.6% of Medicaid revenue, rank #11 of 196 in-state) — place the firm among the top in-state performers for several high-volume analytes.
Operationally, the provider’s Medicaid and Medicare portfolios show very large claim counts at low average paid/claim for several items (e.g., Medicare P9603 219K claims at $1 avg paid/claim; Medicaid 85025 131.5K claims at $2 avg paid/claim), which is consistent with a high-throughput, volume-driven business model that relies on scale rather than high per-procedure margins. The presence of both high claim counts and modest per-claim payments implies logistics and specimen-collection efficiency are likely core competencies.
Clinically, the dominant test mix centers on routine monitoring and screening: Medicare and Medicaid top lists include 80053 (CMP), 85025 (CBC), 84443 (TSH), 80061 (lipid panel), 83036 (A1C), 82306 (vitamin D), and 82607 (B12). This pattern indicates the lab primarily supports chronic disease management, preventive screening, and standard outpatient monitoring rather than specialized anatomic pathology or low-volume specialty molecular assays.
The provider has an established enrollment history with an NPI enumerated on 2013-07-11 (~13 years ago), supporting the conclusion that its high-volume billing profile is backed by more than a decade of operational tenure. That longevity, combined with top-percentile ranks on multiple common lab and collection codes, suggests an entrenched regional presence and an operational platform capable of sustaining large specimen-collection volumes.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
186 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 34,200 | $10 | $376.2K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 41,090 | $10 | $328.7K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 26,810 | $10 | $268.1K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 15,600 | $20 | $249.6K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 29,880 | $10 | $239K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 218,980 | $1 | $219K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 12,990 | $10 | $168.8K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 12,940 | $10 | $129.4K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 8,530 | $20 | $128K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 2,100 | $40 | $84.2K |
Showing 1–10 of 186
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 186 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
186 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87798 | 10 | 10 | 650 | $30 | $553.2K |
| 86003 | 4 | 10 | 48,520 | $10 | $302K |
| P9603 | 2 | 10 | 139,860 | $1 | $213.5K |
| 82784 | 4 | 10 | 11,640 | $10 | $197.3K |
| 83521 | 4 | 10 | 8,690 | $20 | $174.5K |
| U0003 | 9 | 10 | 230 | $70 | $166.6K |
| P9604 | 1 | 10 | 90 | $10 | $97.3K |
| 80197 | 5 | 10 | 4,700 | $10 | $61.4K |
| 86235 | 10 | 20 | 130 | $20 | $59.5K |
| 83013 | 4 | 10 | 60 | $70 | $58.3K |
Showing 1–10 of 186
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
170 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 138,440 | $10 | $1.1M |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 49,040 | $10 | $441.4K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 110,930 | $1 | $332.8K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 4,900 | $60 | $303.9K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 131,450 | $1 | $262.9K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 63,950 | $1 | $255.8K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 63,080 | $1 | $252.3K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 17,230 | $10 | $223.9K |
| 86480 | The lab analyst performs a test to evaluate a cell mediated immunity gamma interferon antigen response to certain tuberculosis, or TB, antibodies. | 5,890 | $30 | $200.3K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 62,960 | $1 | $188.9K |
Showing 1–10 of 170
How this provider's Medicaid billing volume and revenue compare to other Arizona providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arizona median
170 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 25 | 110 | 960 | $70 | $1.7M |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 7 | 20 | 250 | $40 | $915.9K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 3 | 30 | 470 | $20 | $761.9K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 10 | 40 | 190 | $30 | $662.3K |
| 87902 | The lab analyst performs the technical lab test to analyze the specific genotype by nucleic acid of a specimen containing hepatitis C virus. | 4 | 10 | 3,410 | $100 | $493.4K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 11 | 20 | 160 | $90 | $459.7K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 83 | 170 | 3,560 | $30 | $397.9K |
| 83013 | The lab analyst tests multiple breath samples for the presence of an isotope that indicates the presence of the H. pylori bacteria. This organism can cause irritation and ulcers of the stomach lining. | 4 | 10 | 70 | $20 | $396.6K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 30 | 60 | 1,000 | $40 | $331.5K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 14 | 100 | 1,040 | $20 | $327.4K |
Showing 1–10 of 170
Other providers in the same ZIP code as Central Clinical Labs Incorporated, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Laboratory Corporation Of America | AZ | Clinical Medical Laboratory | $38.5M | $265.9M |
| Caris Mpi, Inc. | AZ | Clinical Medical Laboratory | $97.4M | $51.7M |
| New Life Wellness Center LLC | AZ | Public Health or Welfare Agency | $0 | $66M |
| Family And Youth Intervention Services | AZ | Community/Behavioral Health Agency | $0 | $16.2M |
| Nebco Associates, Inc. | AZ | Transportation Broker | $0 | $11.4M |
| Accupath Diagnostic Laboratories Inc | AZ | Clinical Medical Laboratory | $3.3M | $4.1M |
| Sahar Samaha | AZ | Anatomic Pathology & Clinical Pathology Physician | $906.4K | $0 |
| Joshua Leonard | AZ | Optometrist | $347.1K | $0 |
| Abida Kadi | AZ | Dermatopathology (Pathology) Physician | $267K | $0 |
| Hema Khurana | AZ | Anatomic Pathology & Clinical Pathology Physician | $235.5K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.